Premier Cross-border Private Equity Investors
Market Opportunity in Asia
Our partners and advisors average over two decades of direct experience investing and operating in Asia. We aim to leverage our expertise in cross-border investing, deal-structuring and operational execution to help our portfolio companies penetrate Asian markets.
Rapidly Aging Asian Population
The number of elderly people in the Asia-Pacific region is rising at an unprecedented rate and it is at the forefront of the global phenomenon of population ageing. By 2050, one in four people in the Asia Pacific region will be over 60 years old. The population of elderly persons (aged 60+) in the region will triple between 2010 and 2050, reaching close to 1.3 billion people
Source: UNFPA Asia and the Pacific
Drastic Rise of Non-communicable Diseases (NCDs)
Noncommunicable diseases are responsible for 80% of all deaths in the Asia Pacific Region. This is likely due to key factors such as the high proportion of daily smokers and increasingly unhealthy dietary habits
Source: World Health Organization
Healthcare Spending Growth Trend (in Trillions)
Healthcare spending in the Asian Pacific region is growing steadily - the overall healthcare spending is projected to surge from 2017's $1.7 trillion to $2.3 trillion by 2026, driven by rising income, increasing health awareness, lifestyle diseases and better access to insurance
Source: L.E.K. Consulting
Why Invest in Cross-border Healthcare Now?
Leveraging our cross-border expertise, vast network of strategic industry contacts, and deep knowledge of the healthcare industry, we intend to achieve compelling risk-adjusted returns for our investors. The fund has identified a handful of attractive sub-sectors that we believe are best-positioned to capture the rapid growth and transformation of both the Asia and U.S. healthcare markets.